Published December 27, 2012 by PR Web St. Louis, MO (PRWEB) December 27, 2012 Pradaxa lawsuits have been consolidated into a Multi-District Litigation being heard in the U.S. District Court,…
Read More
The blood thinner medication known as Pradaxa is currently under scrutiny, as the drug has been known to cause severe bleeding, sometimes resulting in death. Pradaxa is a drug manufactured…
Read More
Court convened in the Pradaxa Multi-District Litigation (MDL) known as In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation) MDL No. 2385 for a Status Conference on January 14, 2013. The…
Read More
On December 19, the U.S. Food and Drug Administration (FDA) released a safety announcement regarding the anticoagulant medicine known as Pradaxa. Pradaxa, known generically as dabigatran etexilate mesylate, is manufactured…
Read More
On December 8, 2012, Boehringer Ingelheim Pharmaceuticals, Inc. delivered a presentation at the 54th Annual Meeting of the American Society of Hematology in Atlanta, Georgia. Boehringer Ingelheim presented new findings…
Read More